Clinical Trial Update: Glasdegib for Chronic Graft-Versus-Host Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update reports termination of the glasdegib study for chronic graft-versus-host disease (and fasciitis) with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fasciitis
• Graft-versus-host Disease

Drugs mentioned

• Glasdegib (Daurismo) (glasdegib)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Chronic Graft Versus Host Disease, Fasciitis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-10-29